Relationship between drug-related problems and health outcomes: a cross-sectional study among cardiovascular patients
- 451 Downloads
Objective To describe drug-related problems (DRPs) and expense problems (EPs) identified by a standardised community pharmacist-based medication review (MR) program among Swiss cardiovascular outpatients (56–75 years old) and to evaluate the need for collaborative pharmacy practice to achieve economic, clinical and humanistic outcomes. Setting A pilot population of 85 cardiovascular outpatients who were customers of 14 community pharmacies (members of the pharmacieplus virtual chain) and insured with Groupe Mutuel health insurance. Method Cross-sectional study of a structured medication review program, conducted by 11 pharmacists in collaboration with 61 general practitioners (GPs), with patient interviews and access to medical data. Main outcome measure Numbers and types of DRPs and EPs within the study population and odds ratios between them, as well as economic, clinical and humanistic outcomes. Results Of the included patients, 91% had at least one DRP or EP. The odds ratios indicated that not being exposed to DRPs was associated with a higher chance of reaching the clinical target (OR: 3.4; IC95%:1.1–10.5; P = 0.01), of having a better physical quality of life than the median (OR: 2.5; IC95%:0.9–7.3; P = 0.05) and having lower total health care costs (OR: 3.2; IC95%:1.1–9.8; P = 0.02). Conclusions This cross-sectional study shows that the control of cardiovascular risk factors, quality of life and healthcare costs are statistically related to the presence of DRPs detected by a community pharmacist-based MR program.
KeywordsCollaborative pharmacy practice Community pharmacy Drug costs Drug-related problems Medication review Quality of life Switzerland
We are grateful to the voluntary participating community pharmacists and GPs; to Prof. Rob Horn for letting us use the MARS-5© and to J.-M. Krähenbühl and the virtual chain pharmacieplus for supporting this university research in community pharmacy practice.
This pilot study was funded by the virtual chain of independent pharmacists pharmacieplus.
Conflict of interests
None to declare.
- 21.Ware JE, Kosinski M, Turner-Bowker DM, Ganiats TG. How to score version 2 to the SF-12 health survey. Lincoln, RI: QualityMetric Inc.;2005. ISBN 1-897810-10-3.Google Scholar
- 22.The Pharmaceutical Care Network Europe Classification V6.2 (document on the Internet). 2010. http://www.pcne.org/Documents/DRP/PCNE%20classification%20V6-2.pdf. Updated 14 Jan 2010, accessed 10 Mar 2010.
- 23.Fernandez-Llimós F, Faus M-J, Gastelurruita MA, Baena MI, Tuneu L, Martinez Martinez F. Systematic identification of negative clinical outcomes from pharmacotherapy. Seguim Farmacoter. 2004;2:195–205.Google Scholar
- 26.Niquille A, Lattmann C, Bugnon O. Medication reviews led by community pharmacists in Switzerland: a qualitative survey to evaluate barriers and facilitators. Pharm Pract (Internet). 2010;8(1):35–42.Google Scholar